Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

316 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Randomised trial of interferon alpha2b plus ribavirin for 48 weeks or for 24 weeks versus interferon alpha2b plus placebo for 48 weeks for treatment of chronic infection with hepatitis C virus. International Hepatitis Interventional Therapy Group (IHIT).
Poynard T, Marcellin P, Lee SS, Niederau C, Minuk GS, Ideo G, Bain V, Heathcote J, Zeuzem S, Trepo C, Albrecht J. Poynard T, et al. Among authors: heathcote j. Lancet. 1998 Oct 31;352(9138):1426-32. doi: 10.1016/s0140-6736(98)07124-4. Lancet. 1998. PMID: 9807989 Clinical Trial.
Hepatitis-B antigen in saliva and semen.
Heathcote J, Cameron CH, Dane DS. Heathcote J, et al. Lancet. 1974 Jan 19;1(7847):71-3. doi: 10.1016/s0140-6736(74)92289-2. Lancet. 1974. PMID: 4129209 No abstract available.
Letter: Multiple sclerosis.
Heathcote JG. Heathcote JG. Lancet. 1975 Feb 8;1(7902):344. doi: 10.1016/s0140-6736(75)91263-5. Lancet. 1975. PMID: 46495 No abstract available.
Spread of acute type-B hepatitis in London.
Heathcote J, Sherlock S. Heathcote J, et al. Lancet. 1973 Jun 30;1(7818):1468-70. doi: 10.1016/s0140-6736(73)91809-6. Lancet. 1973. PMID: 4123138 No abstract available.
Intrinsic factor theory of Castle.
Mooney FS, Heathcote JG. Mooney FS, et al. Among authors: heathcote jg. Lancet. 1968 Jan 13;1(7533):93. doi: 10.1016/s0140-6736(68)90102-5. Lancet. 1968. PMID: 4169146 No abstract available.
316 results